182
Participants
Start Date
March 31, 2010
Primary Completion Date
November 30, 2010
Study Completion Date
December 31, 2012
Gardemont Goldtrain Plus (GT+)
Four tablets of 760 mg of GT+ administered three times a day for seven consecutive days and similar placebo tablets given to the control arm
RECRUITING
Revivim and Mashabei Sadeh Clalit Clinics, Beersheba
Lead Sponsor
Collaborators (1)
Ben-Gurion University of the Negev
OTHER
Clalit Health Services
OTHER
Meir Medical Center
OTHER